ARS Pharmaceuticals Inc — Quarterly Cash Flow (NASDAQ:SPRY) | MetaTrader

Open full chart

Financials

Overview 声明 Statistics Dividends

Quarterly Annual

Total assets 217.6 M351.15 M327.32 M313.47 M372.8 M Total liabilities 16.62 M94.36 M98.34 M121.15 M225.15 M Total equity 200.98 M256.8 M228.97 M192.32 M147.66 M Total liabilities & shareholders' equities 217.6 M351.15 M327.32 M313.47 M372.8 M Total debt ————— Net debt —————

新闻

ARS Pharmaceuticals Stock: Climbing Neffy Sales Global Expansion Re-Rate (NASDAQ:SPRY)

What's Going On With ARS Pharmaceuticals Stock Friday? - ARS Pharmaceuticals (NASDAQ:SPRY)

Why Is Aquestive Therapeutics Stock Falling Today? - Aquestive Therapeutics (NASDAQ:AQST)

中国批准首款社区使用的过敏反应鼻喷雾剂

China approves first community use epinephrine nasal spray for allergies

ARS制药公司首席商务官Chakma出售价值147万美元股票

Dorsey，ARS Pharma首席运营官出售价值19万美元SPRY股票

ARS Pharma CBO Chakma sells shares worth $1.47 million

Dorsey, ARS Pharma COO, sells $190k in SPRY stock

ARS Pharmaceuticals, Inc. (SPRY) Q3 2025 Earnings Call Transcript

ARS制药公司股价因强劲第三季度销售额上涨，Raymond James重申强力买入评级

William Blair重申ARS制药公司"跑赢大盘"评级，基于neffy数据